C07D 239/42
One nitrogen atom
Official title: One nitrogen atom (nitro radicals C07D239/30)
C07D239/42 (One nitrogen atom) appears on 2,319 US grants and 2,235 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,319
- Published applications
- 2,235
- Assignees
- 1,018
- Inventors
- 7,715
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 17 | 0 |
| 1977 | 11 | 0 |
| 1978 | 16 | 0 |
| 1979 | 9 | 0 |
| 1980 | 18 | 0 |
| 1981 | 23 | 0 |
| 1982 | 21 | 0 |
| 1983 | 20 | 0 |
| 1984 | 39 | 0 |
| 1985 | 28 | 0 |
| 1986 | 30 | 0 |
| 1987 | 37 | 0 |
| 1988 | 32 | 0 |
| 1989 | 35 | 0 |
| 1990 | 36 | 0 |
| 1991 | 34 | 0 |
| 1992 | 26 | 0 |
| 1993 | 29 | 0 |
| 1994 | 28 | 0 |
| 1995 | 31 | 0 |
| 1996 | 36 | 0 |
| 1997 | 46 | 0 |
| 1998 | 34 | 0 |
| 1999 | 41 | 0 |
| 2000 | 24 | 0 |
| 2001 | 36 | 7 |
| 2002 | 42 | 41 |
| 2003 | 41 | 79 |
| 2004 | 38 | 120 |
| 2005 | 45 | 128 |
| 2006 | 60 | 94 |
| 2007 | 62 | 102 |
| 2008 | 54 | 113 |
| 2009 | 76 | 125 |
| 2010 | 82 | 121 |
| 2011 | 75 | 93 |
| 2012 | 89 | 96 |
| 2013 | 102 | 118 |
| 2014 | 110 | 113 |
| 2015 | 107 | 128 |
| 2016 | 80 | 81 |
| 2017 | 96 | 110 |
| 2018 | 65 | 65 |
| 2019 | 65 | 68 |
| 2020 | 60 | 71 |
| 2021 | 40 | 69 |
| 2022 | 47 | 65 |
| 2023 | 38 | 82 |
| 2024 | 42 | 70 |
| 2025 | 37 | 35 |
| 2026 | 29 | 41 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Preparation method for pyrimidine-2-amine8 Sep 2026US 12,729,185 B2Institute for Basic Science
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Methods and compositions for targeting Tregs using CCR8 inhibitors28 Jul 2026US 12,692,239 B2Nanjing Immunophage Biomedical Co., Ltd.
- Aptamer nucleic acid molecule, and complex and application thereof23 Jun 2026US 12,662,676 B2East China University of Science and Technology
- 4-(imidazo[1,2-a]pyridin-3-yl)-pyrimidine16 Jun 2026US 12,655,142 B2Merck Patent GmbH
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Inhibitors of spinster homolog 2 (spns2) for use in therapy1 Oct 2026US 2026/0297044 A1University of Virginia Patent Foundation
- Modulators of sortilin activity24 Sep 2026US 2026/0285802 A1
- Hiv-1p rotease inhibitors and uses thereof17 Sep 2026US 2026/0272926 A1Purdue Research Foundation
- Pyrido[3,4-d]pyrimidinone and pyrimdllne aryl hydrocarbon receptor antagonists and uses thereof17 Sep 2026US 2026/0272944 A1
Most cited
By later US patents
- Pyrimidine, cyanoguanidines as K-channel blockers1,019US 5,633,374 AThe Upjohn Company · 1997
- Substituted 2-anilinopyrimidines useful as protein kinase inhibitors201US 5,958,935 ACelltech Therapeutics Limited · 1999
- Bi-aryl meta-pyrimidine inhibitors of kinases194US 7,528,143 B2TargeGen, Inc. · 2009
- Pyrimidine derivatives189US 5,260,440 AShionogi Seiyaku Kabushiki Kaisha · 1993
- Substituted 2-anilinopyrimidines useful as protein kinase inhibitors189US 6,235,746 B1Celltech Therapeutics Limited · 2001